How you can helpIf you have been diagnosed with one of these advanced cancers and have been treated with Avastin prior to 2013, please consider joining the InVite Study. If you know someone who is eligible, please help spread the word about this innovative study: link to find out more.For more information about the InVite study email [email protected]
By combining participants’ genetic data with survey responses, we hope to discover new genetic markers for these advanced diseases, and to understand why some people respond well to treatment when others do not. 23andMe is excited about partnering with Genentech on this new and innovative web-based approach to data collection and research process.(While this study may generate important scientific findings, participants should not expect that these findings will change how they are or have been treated for their disease.) We appreciate the strong partnerships of breast cancer advocacy groups that have supported and raised awareness for the InVite Study over the last year. These groups include the Avon Foundation for Women, BreastCancer.Org, Living Beyond Breast Cancer, the Metastatic Breast Cancer Network, the Triple Negative Breast Cancer Foundation, the Cancer Support Community, Facing Our Risk for Cancer Empowered (FORCE), EmpowHER, and Stand Up To Cancer. As we expand the study, we are excited to announce new partnerships with the Kidney Cancer Association, LUNGevity, Fight Colorectal Cancer, National Lung Cancer Partnership, Colon Cancer Alliance, and the Musella Foundation.